VX1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 408.05 EUR -1.79%

Market Cap: €48.3B

V	Vertex Pharmaceuticals Inc SWB:VX1	US
T	Tetra Tech Inc SWB:TT6	US
	Arca Continental SAB de CV OTC:EMBVF	MX
H	Heineken NV XMUN:HNK1	NL
M	Masco Corp SWB:MSQ	US
F	Flex Ltd BMV:FLEXN	SG
Q	Qualcomm Inc F:QCI	US
K	Kellogg Co XBER:KEL	US
G	Garmin Ltd XBER:GEY	CH
C	Carrefour SA DUS:CAR	FR
R	Raytheon Technologies Corp XETRA:5UR	US

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 35%

Exceptional Free Cash Flow Margin

29%

Strong 3Y Average Free Cash Flow Margin

17%

Declining Free Cash Flow Margin

41% > 29%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.